JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120414

MRS 2179, P2Y1 antagonist

Be the first to review this product! Submit a review

|

(6 Publications)

MW 460.27 Da, Purity >98%. Potent, selective, competitive P2Y1 antagonist (Ki = 100 nM). Inhibits ATP induced glutamate release *in vitro* and inhibits ADP ability to evoke platelet shape change and aggregation.
1 Images
Chemical Structure - MRS 2179, P2Y1 antagonist (AB120414)
  • Chemical Structure

Lab

Chemical Structure - MRS 2179, P2Y1 antagonist (AB120414)

2D chemical structure image of ab120414, MRS 2179, P2Y1 antagonist

Key facts

CAS number

101204-49-3

Purity

>98%

Form

Solid

form

Molecular weight

460.27 Da

Molecular formula

C<sub>1</sub><sub>1</sub>H<sub>2</sub><sub>2</sub>N<sub>6</sub>O<sub>1</sub><sub>0</sub>P<sub>2</sub>

PubChem

71308613

Nature

Synthetic

Solubility

Soluble in water to 100 mM

Biochemical name

MRS 2179 ammonium salt hydrate, >=98% (HPLC)

Biological description

Potent, selective, competitive P2Y1 antagonist (Ki = 100 nM). Inhibits ATP induced glutamate release *in vitro* and inhibits ADP ability to evoke platelet shape change and aggregation.

Canonical smiles

CNC1=C2C(=NC=N1)N(C=N2)C3CC(C(O3)COP(=O)(O)O)OP(=O)(O)O.N.O

Isomeric smiles

CNC1=C2C(=NC=N1)N(C=N2)[C@H]3C[C@@H]([C@H](O3)COP(=O)(O)O)OP(=O)(O)O.N.O

InChi

InChI=1S/C11H17N5O9P2.H3N.H2O/c1-12-10-9-11(14-4-13-10)16(5-15-9)8-2-6(25-27(20,21)22)7(24-8)3-23-26(17,18)19;;/h4-8H,2-3H2,1H3,(H,12,13,14)(H2,17,18,19)(H2,20,21,22);1H3;1H2/t6-,7+,8+;;/m0../s1

InChiKey

DEQIORFOBOEGKZ-ZJWYQBPBSA-N

IUPAC Name

azane;[(2R,3S,5R)-5-[6-(methylamino)purin-9-yl]-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate;hydrate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 15:18944 PubMed40442293

2025

Amyloid-β-induced alteration of fast and localized calcium elevations in cultured astrocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Kaito Nakata,Joe Sakamoto,Kohei Otomo,Masanao Sato,Hirokazu Ishii,Motosuke Tsutsumi,Ryosuke Enoki,Tomomi Nemoto

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 72:41-60 PubMed38158780

2024

ADP-mediated Modulation of Intracellular Calcium Responses in Chromaffin Cells: The Role of Ectonucleoside Triphosphate Diphosphohydrolase 2 on Rat Adrenal Medulla Function.

Applications

Unspecified application

Species

Unspecified reactive species

Satsuki Maesawa,Takuya Yokoyama,Wakana Sakanoue,Yoshio Yamamoto,Masato Hirakawa,Hirohisa Shiraishi,Kenichi Sato,Tomoyuki Saino

World journal of gastroenterology 23:6339-6349 PubMed28974901

2017

P2Y1R is involved in visceral hypersensitivity in rats with experimental irritable bowel syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Wu,Yan Cheng,Rong Zhang,Dong Liu,Yu-Mei Luo,Kun-Lun Chen,Song Ren,Jun Zhang

Journal of cell science 127:4964-73 PubMed25271060

2014

P2Y₆ receptor inhibition perturbs CCL2-evoked signalling in human monocytic and peripheral blood mononuclear cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hinnah Campwala,Darren W Sexton,David C Crossman,Samuel J Fountain

Neurochemical research 39:2240-50 PubMed25186167

2014

P2Y13 receptor-mediated rapid increase in intracellular calcium induced by ADP in cultured dorsal spinal cord microglia.

Applications

Unspecified application

Species

Unspecified reactive species

Junwei Zeng,Gaoxia Wang,Xiaohong Liu,Chunmei Wang,Hong Tian,Aidong Liu,Huan Jin,Xiaomei Luo,Yuanshou Chen

Journal of medicinal chemistry 42:1625-38 PubMed10229631

1999

Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.

Applications

Unspecified application

Species

Unspecified reactive species

E Nandanan,E Camaioni,S Y Jang,Y C Kim,G Cristalli,P Herdewijn,J A Secrist,K N Tiwari,A Mohanram,T K Harden,J L Boyer,K A Jacobson
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com